Home

Marc A Began

CIK 1821352 · EVP & General Counsel · last filed 2026-08-12

Marc A Began is an EVP & General Counsel who has filed 22 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for AXGN, was dated Aug 12, 2026. Across all open-market trades the lifetime net is −$4.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions. 12 SEC filings were submitted jointly with ABIOMED INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.11M

Companies

2

Total Filings

22

Lifetime Open-Market Net

-$4.76M

Filer Profile

Reported Address
111 W OAK AVE
5TH FLOOR
TAMPA, FL 33602
Related Filers
ABIOMED INC — 12 joint filings, latest 2022-12-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AXGN EVP & General Counsel 50,135 $42.16 $2.11M -$3.88M 9 2026-08-12
ABIOMED INC (ABMD) Delisted VP & GENERAL COUNSEL 13,785 $381.02 $5.25M -$875.4K 10 2022-11-08

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-12 AXGN Mixed — -$2.64M EDGAR
2026-08-10 AXGN Notice (144) −67,500 -$3.13M EDGAR
2026-03-02 AXGN Mixed +31,850 -$414.9K EDGAR
2025-12-12 AXGN Sell (S) −13,222 -$396.7K EDGAR
2025-12-11 AXGN Notice (144) −13,222 -$396.7K EDGAR
2025-12-10 AXGN Sell (S) −9,278 -$289.5K EDGAR
2025-12-05 AXGN Grant (A) +22,500 $0 EDGAR
2025-03-26 AXGN Grant (A) — $0 EDGAR
2025-03-05 AXGN Mixed +16,599 -$108.3K EDGAR
2025-02-26 AXGN Mixed +1,686 -$13.4K EDGAR
Showing 1–10 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.